Elliot Sigal Insider Profile
4 Followers
Elliot Sigal, EVP, CSO & President R&D, Director at Bristol-Myers Squibb, holds 0.00 shares in Spark Therapeutics (Ticker: ONCE), holds 22.62K shares in Mead Johnson (Ticker: MJN), holds 195.30K shares in Bristol-Myers Squibb (Ticker: BMY).
Elliot Sigal's Trading History
| ONCESpark Therapeutics | Dec 17, 2019 | ― | Uninformative Sell | 1.63M | $0.00 | |
| MJNMead Johnson | Jun 15, 2017 | ― | Uninformative Sell | 2.40M | $2.04M | |
| BMYBristol-Myers Squibb | Jun 05, 2013 | EVP, CSO & President R&D, Director | Uninformative Sell | 4.03M | $12.17M |
You May Also Like
Elliot Sigal insider profile FAQ
What is the percentage of profitable transactions made by Elliot Sigal?
The percentage of profitable transactions made by Elliot Sigal is 33%.
What is the average return per transaction made by Elliot Sigal?
The average return per transaction made by Elliot Sigal is -0.50%.
What stocks does Elliot Sigal hold?
Elliot Sigal holds: BMY, ONCE, MJN stocks.
What was Elliot Sigal’s latest transaction?
Elliot Sigal’s latest transaction was an Uninformative Sell of $1.63M.
What was Elliot Sigal's most profitable transaction?
Elliot Sigal’s most profitable transaction was an Informative Buy of ONCE stock on April 16, 2018. The return on the trade was 42.40%.
What is Elliot Sigal's role in Bristol-Myers Squibb?
Elliot Sigal's role in Bristol-Myers Squibb is EVP, CSO & President R&D, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
